Labor, Induced Clinical Trial
Official title:
Mifepristone Outpatient Labour Induction
The number of women having an induction of labour is increasing and is currently used in 33% of pregnancies for a range of medical reasons. The majority of women are admitted to hospital to have their labour induced, using methods which are protracted and associated with a poor birth experience, making them both costly and unpopular. Further, current methods of outpatient induction are unsuitable, unsafe and/or have a poor acceptability. The COVID-19 pandemic has driven a reduction in the number of face-to-face interactions taking place across all areas of medicine. Proving the efficacy and safety of Mifepristone would significantly reduce pre-labour admission rates and hospital length of stay for pregnant women, who are at particularly higher risk of COVID-19, and reduce delivery costs.
The study is a double blinded, two arms, multi-centre randomised controlled clinical trial to investigate the clinical effectiveness, safety and resource utilisation of intervention for the induction of labour in low-risk women admitted to the hospital. Subjects will be randomised 1:1 to one of the two arms to receive: Arm 1: Mifepristone + standard of care Arm 2: Placebo + standard of care The study treatment will commence from the administration of the Mifepristone or placebo. The participants will be assessed 48 hours after treatment regimen will be completed as an in-patient. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02902653 -
Efficacy and Safety of Hourly Titrated Misoprostol Versus Vaginal Dinoprostone and Misoprostol for Cervical Ripening and Labor Induction
|
Phase 4 | |
| Completed |
NCT05100264 -
Effect of Acidic Vaginal pH on the Efficacy of Dinoprostone for Labor Induction
|
N/A | |
| Completed |
NCT01962831 -
Randomized Controlled Trial: Induction of Labour of Obese Women With Dinoprostone or Single Balloon Catheter
|
N/A | |
| Recruiting |
NCT05857059 -
Misoprostol for Induction of Labor in Obese Women: Comparison Between 25 and 50 mcg Oral Administration
|
N/A | |
| Completed |
NCT03665688 -
Comparing Outpatient to Inpatient Cervical Ripening Using Dilapan-S®
|
N/A | |
| Completed |
NCT00992524 -
Oral Titrated Misoprostol for Induction of Labour
|
N/A | |
| Completed |
NCT00259103 -
Recombinant Human Relaxin (rhRlx) in Pregnant Women Scheduled for Induction of Labor
|
Phase 2 | |
| Completed |
NCT04755218 -
Labor Induction With Oral Versus Vaginal Misoprostol
|
||
| Completed |
NCT04746248 -
Outpatient Labor Induction Using Oral Misoprostol in Norway
|
N/A | |
| Completed |
NCT05838313 -
Should I Have an Elective Induction?
|
N/A | |
| Completed |
NCT03140488 -
Oxytocin Dosage to Decrease Induction Duration
|
Phase 4 | |
| Recruiting |
NCT02486679 -
A Trial of Prostaglandin E2 Tablets Versus Foley Catheter for Labor Induction
|
Phase 4 | |
| Terminated |
NCT01641601 -
Prehospital Cervical Ripening Before Induction and the Maternal Experience
|
N/A | |
| Completed |
NCT00465998 -
Study of Ultrasound Imaging to Predict Time and Outcome in Pregnancies With Induced Labor
|
N/A | |
| Completed |
NCT00393731 -
A Randomized, Control Trial for Preinduction Cervical Ripening
|
Phase 2 | |
| Completed |
NCT00545194 -
Cervical Ripening Before Induction of Labour at Term: a Randomised Comparison of Prostin vs Propess
|
Phase 3 | |
| Completed |
NCT05874024 -
Induction of Labour With a Double Balloon Catheter
|
||
| Completed |
NCT03407625 -
Foley Bulb With Oral Misoprostol for Induction of Labor
|
N/A | |
| Completed |
NCT04731896 -
Early Versus Late Amniotomy During Labor Induction in Women With Bishop's Score of ≥ 6
|
N/A | |
| Terminated |
NCT02373800 -
Elastography for Evaluating Cervical Maturity in Preparation for Labor Induction at 37 to 42 Weeks of Gestation
|